REMODULIN (treprostinil)
United therap
Patent: 10,076,505
Expiration: Dec 16, 2024
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com